Conduit Pharmaceuticals (CDT) Stock Chart & Stock Price History $2.76 -0.12 (-4.17%) As of 06/30/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Conduit Pharmaceuticals Stock Price Performance The Conduit Pharmaceuticals (CDT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 99.82%, with a year-to-date return of -97.32%. In the past month, the stock has decreased 16.36%, reflecting recent market activity. As of the latest close, Conduit Pharmaceuticals traded at $2.76 with a market cap of $2.21 million and volume of 498,194 shares. Receive CDT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Conduit Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+9.96%1 Month Performance-16.36%3 Month Performance-74.52%Year-To-Date Performance-97.32%1 Year Performance-99.82% CDT Stock Chart for Tuesday, July, 1, 2025 CDT Chart by TradingView Conduit Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/30/2025$2.88$2.76-4.17%$2.89$2.58498,194 shs$2.21 million06/27/2025$2.51$2.88+14.74%$3.05$2.551.36 million shs$2.30 million06/26/2025$2.45$2.51+2.45%$2.60$2.37369,005 shs$2.01 million06/25/2025$2.30$2.45+6.52%$2.55$2.33870,034 shs$1.96 million06/24/2025$2.31$2.30-0.43%$2.58$2.28394,607 shs$1.84 million06/23/2025$2.30$2.31+0.43%$2.38$2.21587,927 shs$1.85 million06/20/2025$2.37$2.30-2.95%$2.43$2.29195,235 shs$1.84 million06/19/2025$2.37$2.37$2.48$2.28266,306 shs$1.90 million06/18/2025$2.30$2.37+3.04%$2.48$2.28266,306 shs$1.90 million06/17/2025$2.30$2.30$2.59$2.24272,230 shs$1.84 million Get the Latest News and Ratings for CDT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Conduit Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 06/16/2025$2.33$2.30-1.29%$2.40$2.23110,947 shs$1.84 million06/13/2025$2.47$2.33-5.67%$2.46$2.31208,046 shs$1.86 million06/12/2025$2.53$2.47-2.37%$2.54$2.41163,977 shs$1.97 million06/11/2025$2.49$2.53+1.61%$2.57$2.43166,309 shs$2.02 million06/10/2025$2.58$2.49-3.49%$2.60$2.43194,034 shs$1.99 million06/09/2025$2.69$2.58-4.09%$2.60$2.50215,337 shs$2.06 million06/06/2025$2.70$2.69-0.37%$2.76$2.58225,117 shs$2.15 million06/05/2025$2.68$2.70+0.75%$2.75$2.53389,753 shs$2.16 million06/04/2025$3.23$2.68-17.03%$2.86$2.455.04 million shs$2.14 million06/03/2025$3.94$3.23-18.02%$3.94$3.031.25 million shs$2.58 million06/02/2025$3.30$3.94+19.39%$4.24$3.501.18 million shs$3.14 million05/30/2025$3.62$3.30-8.84%$3.75$3.21276,293 shs$2.63 million05/29/2025$3.69$3.62-1.90%$3.95$3.50103,806 shs$2.89 million Related Companies GENPREX Stock Price Chart Nuvilex Stock Price Chart AIM ImmunoTech Stock Price Chart Silexion Therapeutics Stock Price Chart Alaunos Therapeutics Stock Price Chart Omega Therapeutics Stock Price Chart IN8bio Stock Price Chart HCW Biologics Stock Price Chart Sunshine Biopharma Stock Price Chart Cardio Diagnostics Stock Price Chart Receive CDT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Conduit Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CDT) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredNvidia’s Huang: AI is going to need 100x more power12Nvidia CEO Jensen Huang didn't mince words. After Nvidia's latest earnings call, Huang said AI now requires...Weiss Ratings | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Conduit Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Conduit Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDT Stock Alerts